Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Plum

Showing results (81-90 of 93) with videos related to

Pageof 10
Sort By:
Biophysical Journal|April 29, 2008
In situ monitoring of the catalytic activity of cytochrome C oxidase in a biomimetic architectureMarcel G Friedrich, Markus A Plum, M Gabriella Santonicola, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|February 24, 2006
2MD, a new anabolic agent for osteoporosis treatmentL A Plum, L A Fitzpatrick, X Ma, et al.
The Journal of Biological Chemistry|June 5, 2015
1,25-Dihydroxyvitamin D3 Controls a Cohort of Vitamin D Receptor Target Genes in the Proximal Intestine That Is Enriched for Calcium-regulating ComponentsSeong Min Lee, Erin M Riley, Mark B Meyer, et al.
Steroids|December 3, 2011
Synthesis and biological activities of vitamin D-like inhibitors of CYP24 hydroxylaseGrazia Chiellini, Simona Rapposelli, Jinge Zhu, et al.
The Journal of Nutrition|February 4, 2015
Cholecalciferol or 25-hydroxycholecalciferol neither prevents nor treats adenomas in a rat model of familial colon cancerAmy A Irving, Lori A Plum, William J Blaser, et al.
European Journal of Medicinal Chemistry|April 14, 2024
Design, synthesis, and biological activity of D-bishomo-1α,25-dihydroxyvitamin D<sub>3</sub> analogs and their crystal structures with the vitamin D nuclear receptorAdrian Fabisiak, Pawel Brzeminski, Rafal R Sicinski, et al.
Development (Cambridge, England)|September 8, 2000
Defective vascular development in connexin 45-deficient miceO Krüger, A Plum, J S Kim, et al.
American Journal of Nephrology|November 24, 2016
2MD (DP001), a Single Agent in the Management of Hemodialysis Patients: A Randomized TrialRavi Thadhani, Julia B Zella, Danielle C Knutson, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|April 21, 2007
Effect of 2-methylene-19-nor-(20S)-1 alpha-hydroxy-bishomopregnacalciferol (2MbisP), an analog of vitamin D, on secondary hyperparathyroidismEduardo Slatopolsky, Jane L Finch, Alex J Brown, et al.
Drugs in R&D|September 15, 2017
Pharmacokinetics of a New Oral Vitamin D Receptor Activator (2-Methylene-19-Nor-(20S)-1α,25-Dihydroxyvitamin D<sub>3</sub>) in Patients with Chronic Kidney Disease and Secondary Hyperparathyroidism on HemodialysisRicha Pandey, Julia B Zella, Jinge G Zhu, et al.
Pageof 10

Showing results (81-90 of 93) with videos related to

Sort By:
Pageof 10
Biophysical Journal|April 29, 2008
In situ monitoring of the catalytic activity of cytochrome C oxidase in a biomimetic architectureMarcel G Friedrich, Markus A Plum, M Gabriella Santonicola, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|February 24, 2006
2MD, a new anabolic agent for osteoporosis treatmentL A Plum, L A Fitzpatrick, X Ma, et al.
The Journal of Biological Chemistry|June 5, 2015
1,25-Dihydroxyvitamin D3 Controls a Cohort of Vitamin D Receptor Target Genes in the Proximal Intestine That Is Enriched for Calcium-regulating ComponentsSeong Min Lee, Erin M Riley, Mark B Meyer, et al.
Steroids|December 3, 2011
Synthesis and biological activities of vitamin D-like inhibitors of CYP24 hydroxylaseGrazia Chiellini, Simona Rapposelli, Jinge Zhu, et al.
The Journal of Nutrition|February 4, 2015
Cholecalciferol or 25-hydroxycholecalciferol neither prevents nor treats adenomas in a rat model of familial colon cancerAmy A Irving, Lori A Plum, William J Blaser, et al.
European Journal of Medicinal Chemistry|April 14, 2024
Design, synthesis, and biological activity of D-bishomo-1α,25-dihydroxyvitamin D<sub>3</sub> analogs and their crystal structures with the vitamin D nuclear receptorAdrian Fabisiak, Pawel Brzeminski, Rafal R Sicinski, et al.
Development (Cambridge, England)|September 8, 2000
Defective vascular development in connexin 45-deficient miceO Krüger, A Plum, J S Kim, et al.
American Journal of Nephrology|November 24, 2016
2MD (DP001), a Single Agent in the Management of Hemodialysis Patients: A Randomized TrialRavi Thadhani, Julia B Zella, Danielle C Knutson, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|April 21, 2007
Effect of 2-methylene-19-nor-(20S)-1 alpha-hydroxy-bishomopregnacalciferol (2MbisP), an analog of vitamin D, on secondary hyperparathyroidismEduardo Slatopolsky, Jane L Finch, Alex J Brown, et al.
Drugs in R&D|September 15, 2017
Pharmacokinetics of a New Oral Vitamin D Receptor Activator (2-Methylene-19-Nor-(20S)-1α,25-Dihydroxyvitamin D<sub>3</sub>) in Patients with Chronic Kidney Disease and Secondary Hyperparathyroidism on HemodialysisRicha Pandey, Julia B Zella, Jinge G Zhu, et al.
Pageof 10